Are statins overprescribed?
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Fleming RM, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
ClinCalc DrugStats Database. Link: http://bit.ly/36vtVqh
Fleming RM (1999) Chapter 64. The Pathogenesis of Vascular Disease. Textbook of Angiology. John C. Chang Editor, Springer-Verlag New York, NY 787-798. Link: http://bit.ly/35rae31
Nuclear Medicine Communications 1997 and Canadian Medical Association.
Fleming RM, Chaudhuri TK, McKusick A (2019) The FDA, HHS, Sestamibi Redistribution and Quantification. Acta Scientific Pharmaceutical Sciences 3: 47-49. Link: http://bit.ly/36rAMAW
Gallagher P (2019) Statin war of words: Matth Hancock dragged into ongoing debate over cholesterol-lowering drug taken by millions of Britons. Link: http://bit.ly/2NYlmxu
Fleming RM, Fleming MR, Chaudhuri TK (2019) Are we prescribing the right diets and drugs for CAD, T2D, Cancer and Obesity? Int J Nuclear Med Radioactive Subs 2: 000115. Link: http://bit.ly/2Rtlw2h
Zeraatkar D, Han A, Guyatt GH, Vernooij RWM, El Dib R, et al. (2019) Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes. A Systematic Review and Meta-analysis of Cohort Studies. Ann Intern Med. Link: http://bit.ly/37BqZtz
Ledford H (2013) Cholesterol limits lose their luster. Nature 494: 410-411. Link: https://go.nature.com/2RqK9wz
Mortensen MB, Flak E (2018) Primary Prevention With Statins in the Elderly. J Am Coll Cardiol 71: 85-94. Link: http://bit.ly/2Rno3uL